Autoimmune Disease Testing Market Size, Share & COVID-19 Impact Analysis, By Product Type (Instruments and Reagents & Consumables), By Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, Vasculitis, Inflammatory Bowel Disease, and Others), By Test Type (Antinuclear Autoantibody, Rheumatoid Factor, C-Reactive Protein, Anti-Thyroglobulin Antibody, and Others), By End-user (Hospital & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI104460

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 10.7% from 2026 to 2034
Unit	Value (USD billion)
Segmentation	By Product Type Instruments Reagents & Consumables
	By Disease Type Rheumatoid Arthritis Systemic Lupus Erythematosus Scleroderma Vasculitis Inflammatory Bowel Disease Others
	By Test Type Antinuclear Autoantibody Rheumatoid Factor C-Reactive Protein Anti-Thyroglobulin Antibody Others
	By End-user Hospital & Clinics Diagnostic Centers Others
	By Region North America (the U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific) Rest of the World